How inducing covariation in simulated HDL-C, triglyceride, and total cholesterol data affects Framingham risk equation results

Value in Health

Volumn 11, Issue 5, 2008, Pages 939-945

  Frick, Kevin D ^a   Sorensen, Sonja V ^b   Hollenbeak, Christopher ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Correlation; Lipids; Risk equations; Simulation modeling

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETIC PATIENT; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONLINEAR SYSTEM; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 52649140052     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00333.x     Document Type: Article

References (14)

1. Gold MR, Siegel JE, Russell LB, et al., eds. Cost-Effectiveness in Health and Medicine. New York : Oxford University Press, 1996.
2. Fry RN, Avey SG, Sullivan SD. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard - a Foundation for Managed Care Pharmacy Task Force report. Value Health 2003 6 : 505 21.
3. Murray CJ, Evans DB, Acharya A, et al. Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ 2000 9 : 235 51.
4. Tarn TYH, Smith MD. Pharmacoeconomic guidelines around the world. ISPOR Connections 2004 10 : 5 15.
5. Haddix AC, Teutsch SM, Corso PS, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation (2nd ed.). New York : Oxford University Press, 2002.
6. Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med 1992 11 : 1685 704.
7. Vickers AJ. How many repeated measures in repeated measures designs? Statistical issues for comparative trials. BMC Med Res Methodol 2003 3 : 22.
8. Cobos A, Jovell AJ, Garcia-Altes A, et al. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis. Clin Ther 1999 21 : 1924 36.
9. U.S. Department of Health and Human Services. National Health and Nutrition Examination Survey 1999-2000. Available from: http://www.cdc.gov/nchs/ about/major/nhanes/nhanes99_00.htm. [Accessed April 18, 2005].
10. U.S. Department of Health and Human Services. National Health and Nutrition Examination Survey 2000-2001. Available from: http://www.cdc.gov/nchs/ about/major/nhanes/nhanes01-02.htm. [Accessed April 18, 2005].
11. NCEP. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, MD : NIH, 2002.
12. Gentle JE. Elements of Computational Statistics (1st ed.). New York : Springer, 2002.
13. D'Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J 2000 139 (2 Part 1 272 81.
14. Packard CJ. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr Opin Lipidol 2006 17 : 412 7.